Dose-related anti-inflammatory/analgesic effects of lornoxicam: A spinal c-Fos protein study in the rat

Inflammation Research

Volumn 47, Issue 1, 1998, Pages 18-25

  Buritova, J ^a   Besson, J M ^a  

^a PSL RESEARCH UNIVERSITY   (France)

Author keywords

c Fos; Carrageenan; Dorsal horn; Lornoxicam; Nociception

Indexed keywords

CARRAGEENAN; LORNOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN C FOS;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EDEMA; INTRAVENOUS DRUG ADMINISTRATION; LUMBAR SPINAL CORD; MALE; NERVE CELL; NOCICEPTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL CORD DORSAL HORN;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; CELL COUNT; EDEMA; INFLAMMATION; MALE; NEURONS; NOCICEPTORS; PIROXICAM; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 0031975471     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050245     Document Type: Article

References (61)

1. Bulfour JA, Fitton A, Barradell LB, Lornoxicam: A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs 1996;51:639-57.
2. Pruss TP, Stroissnig H, Radhofer-Welte S, Wendtlandt W, Mehdi N, Takacs F, et al. Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam. Postgrad Med J 1990;66(Suppl 4):S18-21.
3. Patel A, Skelly AM, Kohn H, Preiskel HW. Double-blind placebocontrolled comparison of the analgesic effects of single doses of lornoxicam and aspirin in patiens with postoperative dental pain. Br Dent J 1941;170:295-9.
4. Berry H, Bird HA, Black C, Blake DR, Freeman AM, Golding DN, et al. A double-blind, multicentre, placebo-controlled trial of lornoxicam in patiens with osteoarthritis of the hip and knee. Ann Rheum Dis 1992;51:238-42.
5. Kidd B, Frenzel W. A multicenter, randomized, double-blind study comparing lornoxicam with diclofenac in osteoarthritis. J Rheumatol 1996;23:1605-11.
6. Flower RJ, Vane JR. Inhibition of prostaglandin biosynthesis. Biochem Pharmacol 1974;23:1439-50.
7. Meade EA, Smith WL, De Witt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993;268:6610-4.
8. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993;90:11693-7.
9. Norholt SE, Sindet-Pedersen S, Bugge C, Branebjerg PA, Ersboll BK, Bastian LH. A randomized, double-blind, placebo-controlled, dose-response study of analgesic effect of lornoxicam after surgical removal of mandibular third molars. J Clin Pharmacol 1995;35:606-14.
10. Rainer F, Klein G, Mayrhofer F, Singer F, Uray H, Kursen FW. A prospective, multi-centre, open-label, uncontrolled phase II study of the local tolerability, safety and efficacy of intramuscular chlortenoxicam in patiens with acute low back pain. Eur J Clin Res 1996;8:1-13.
11. Morgan JI. Proto-oncongene expression in the nervous system. Discussions in Neuroscience. Amsterdam: Elsevier, 1991.
12. Morgan JI, Curran T. Immediate-early genes: Ten years on. Trends Neurosci 1995;18:66-7.
13. Hughes P, Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated expression within the nervous system. Pharmacol Rev 1995;47:133-78.
14. Zieglgänsberger W, Tölle TR. The pharmacology of pain signalling. Curr Opin Neurobio 1993;3:611-8.
15. Abbadie C, Honoré P, Besson J-M. Postsynaptic changes during sustained primary afferent fibre stimulation as revealed by c-Fos immunohistochemistry in the rat spinal cord. In: Urban L. Dray A, Jeftinija S, Reeh P, Woolf CJ, editors. The cellular mechanisms of sensory processing. Berlin: Laszlo Urban, 1994a;449-71.
16. Munglani R, Hunt SP. Molecular biology of pain. Br J Anaesth 1995;75:186-92.
17. Presley RW, Ménetrey D, Levine JD, Basbaum AI. Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. J Neurosci 1990;10: 323-35.
18. Gogas KR, Presley RW, Levine JD, Basbaum AI. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: Correlation of nociceptive behavior and c-fos expression. Neuroscience 1991;42:617-28.
19. Jasmin L, Wang H, Tarey-Hornoch K, Levine JD, Basbaum AI. Differential effects of morphine on noxious stimulus-evoked Fos-like immunoreactivity in subpopulation of spinoparabrachial neurons. J Neurosci 1994;14:7252-60.
20. Honoré P, Chapman V, Buritova J, Besson J-M. When is the maximal effect of pre-administered systemic morphine on carrageenin evoked spinal c-Fos expression in the rat? Brain Res 1995;705:91-6.
21. Hammond DL, Presley RW, Gogas KR, Basbaum AI. Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat. J Comp Neurol 1992;315:244-53.
22. Tölle TR, Castro-Lopes JM, Comibra A, Zieglgänsberger W. Opiates modify induction of c-fos proto-oncogene in the spinal cord of the rat following noxious stimulation. Neurosci Lett 1990;111:46-51.
23. Tölle TR, Castro-Lopes JM, Zieglgänsberger W. C-fos induction in the spinal cord following noxious stimulation: Prevention by opiates but not by NMDA antagonists. In: Bond MR, Charlton JE, Woolf CJ, editors. Proceedings of the VIth world congress on pain. Amsterdam: Elsevier, 1991:299-305.
24. Tölle TR, Herdegen T, Schadrack J, Bravo R, Zimmermann M, Zieglgänsberger W. Application of morphine prior to noxious stimulation differentially modulates expression of Fos, Jun and Krox-24 proteins in rat spinal cord neurons. Neuroscicnce 1994; 58:305-21.
25. Tölle TR, Schadrack J, Castro-Lopes JM, Evan G, Roques BP, Zieglgänsherger W. Effects of Kelatorphan and morphine before and after noxious stimulation on immediate-early gene expression in rat spinal cord neurons. Pain 1994;56:103-12.
26. Abbadie C, Honoré P, Fournié-Zaluski MC, Roques BP, Besson J-M. Effects of opioids and non-opioids on c-Fos immunoreactivity induced in rat lumbar spinal cord neurons by noxious heat stimulation. Eur J Pharmacol 1994;258:215-27.
27. Abbadie C, Honoré P, Besson J-M. Intense cold noxious stimulation of the rat hindpaw induces c-fos expression in lumbar spinal cord neurons. Neuroscience 1994;59:457-68.
28. Abbadie C, Besson J-M. Effects of morphine and naloxone on basal and evoked Fos-like immunoreactivity in lumbar spinal cord neurons of arthritic rats. Pain 1993;52:29-39.
29. Abbadie C, Besson J-M. Chronic treatments with aspirin or acetaminophen reduce both the development of polyarthritis and fos-like immunoreactivity in rat lumbar spinal cord. Pain 1994; 57:45-54.
30. Honoré P, Buritova J, Besson JM. Aspirin and acetaminophen reduced both Fos expression in rat lumbar spinal cord and inflammatory signs produced by carrageenin inflammation. Pain 1995;63:365-75.
31. Honoré P, Buritova J, Besson JM. Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: The effects of indomethacin. Eur J Pharmacol 1995;272:249-59.
32. Buritova J, Honoré P, Chapman V, Besson J-M. Concurrent reduction of inflammation and spinal Fos-LI neurons by systemic diclofenac in the rat. Neurosci Lett 1995;188:175-8.
33. Buritova J, Honoré P, Chapman V, Besson J-M. Carrageenan oedema and spinal Fos-LI neurons are reduced by piroxicam in the rat. Neuroreport 1995;6:1257-60.
34. Buritova J, Honoré P, Besson J-M. Ketoprofen produces profound inhibition of spinal c-Fos protein expression resulting from an inflammatory stimulus but not from noxious heat. Pain 1996; 67:379-89.
35. Buritova J, Chapman V, Honoré P, Besson J-M. Interactions between NMDA and prostaglandin receptor-mediated events in model of inflammatory nociception. Eur J Pharmacol 1996;303: 91-100.
36. Winter CA, Risley EA, Nuss GW. Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962;111:544-7.
37. Di Rosa M, Giroud JP, Willoughby DA. Studies of the mediators of the acute inflammatory-response induced in rats in different sites by carrageenin and turpentine. J Pathol 1971;104:15-29.
38. Kayser V, Guilbaud G. Local and remote modifications of nociceptive sensitivity during carrageenin-induced inflammation in the rat. Pain 1987;28:99-107.
39. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77-88.
40. Iadarola MJ, Brady LS, Draisci G, Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: Stimulus specificity, behavioral parameters and opioid receptor binding. Pain 1988;35:313-26.
41. Joris J, Costello A, Dubner R, Hargreaves K. Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain 1990;43:95-103.
42. Draisci G, Iadarola MJ. Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Mol Brain Res 1989;6:31-7.
43. Noguchi K, Kowalski K, Traub R, Solodkin A, Iadarola MJ, Ruda MA. Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons. Mol Brain Res 1991;10: 227-33.
44. Noguchi K, Duhner R, Ruda MA. Preproenkephalin mRNA in spinal dorsal horn neurons is induced by peripheral inflammation and is co-localized with Fos and Fos-related proteins. Neuroscience 1992;46:561-70.
45. Buritova J, Besson J-M. Revelation of potent anti-inflammatory/ analgesic effects of lornoxicam: A spinal c-Fos expression study. Abstracts of International Conference on Inflammopharmacology. San Francisco: Moorley's, 1997;52-3.
46. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109-10.
47. Buritova J, Honoré P, Chapman V, Besson J-M. Enhanced effects of co-administered dexamethasone and diclofenac on inflammatory pain processing and spinal c-Fos expression in the rat: Synergistic mechanisms. Pain 1996;64:559-68.
48. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxydase complex (ABC) in immunoperoxydase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
49. Menétrey D, de Pommery J, Baimbridge KG, Thomasset M. Calbindin-D28K (CaBP28k)-like immunoreactivity in ascending projections. I. Trigemial nucleus caudalis and dorsal vagal complex projections. Eur J Neurosci 1992;4:61-9.
50. Rexed B. The cytoarchitectonic organization of the spinal cord in the cat. J Comp Neurol 1952;96:415-95.
51. Molander C, Xu Q, Grant G. The cytoarchitectonic organization of the spinal cord in the rat: I. The lower thoracic and lumbosacral cord. J Comp Neurol 1984;230:133-41.
52. Molander C, Grant G. Laminar distribution and somatotopic organization of primary afferent fibers from hindlimb nerves in the dorsal horn. A study by transganglionic transport of horse-radish peroxidase in the rat. Neuroscience 1986;19:297-312.
53. Besson J-M, Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol Rev 1987;67:67-186.
54. Herdegen T, Kovary K, Leah J, Bravo R. Specific temporal and spatial distribution of JUN, FOS and KROX-24 proteins in spinal neurons following noxious transsynaptic stimulation. J Comp Neurol 1991;313:178-91.
55. Malmberg AB, Yaksh TL. Antinociceptive effect of spinally delivered prostaglandin E receptor antagonists in the formalin test on the rat. Neurosci Lett 1994;173:193-6.
56. Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992;263:136-46.
57. Malmberg AB, Yaksh TL. Antinociception produced by spinal delivery of the S and R enantiomers of flurbiprofen in the formalin test. Eur J Pharmacol 1994;256:205-9.
58. Jurna I, Brune K. Central effect of the non-steroid anti-inflammatory agents, indomethacin, ibuprofen, and diclofenac, determined in C-fibre-evoked activity in single neurones of the rat thalamus. Pain 1990;41:71-80.
59. Jurna I, Spohrer B, Bock R. Intrathecal injection of acetylsalicylic acid, salicylic acid and indomethacin depresses C fibre-evoked activity in the rat thalamus and spinal cord. Pain 1992; 49:249-56.
60. Alhava E. Reported adverse drug reactions and consumption of non-steroidal anti-inflammatory drugs. Pharmacol Toxicol 1994; 75 Suppl 11:37-43.
61. Buritova J, Chapman V, Honoré P, Besson J-M. Selective cyclooxygcnase-2 inhibition reduces carrageenan oedema and spinal c-Fos expression in the rat. Brain Res 1996;715:217-20.